This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
VetPlus continues international expansion in South America and Africa
We are proud to celebrate another successful year after we continued to expand our international distribution network in 2023, appointing our first Distributor in South America.
Distribution of our core range of products, which includes SYNOQUIN®, CALMEX® and AKTIVAIT®, began in Ecuador in May 2022. Since then, further deals have been signed with distributors across six Latin American countries, including Peru, Costa Rica, Guatemala, Chile, Paraguay, Bolivia and Panama, with sales expected to begin in Peru in February 2024.
The success has been driven by a growing our team in the market, with three employees now based in our VetPlus Regional Support Office in Buenos Aires, Argentina.
Our expansion into South America comes alongside a similar period of growth in Africa, where we currently have distributors in Egypt and Morocco.
In 2023, we hired our first Business Unit Manager, Kelechi Osuji, based, in Lagos, Nigeria, to support plans to sign our first sub-Saharan distribution partner.
Sam Wright, Sales Director at VetPlus, said: 
It’s been a hugely successful year for us as we continue to bring the best in class in veterinary nutraceuticals to vet practices around the world. 
The progress we’ve made in the last 12 months alone is a testament to the hard work of our international team and we have big ambitions to continue expanding both in South America, Africa and beyond.
We have been leading the development of nutraceuticals within the UK veterinary profession for over 25 years, with over 3,000 veterinary practices across the country recommending our products.
This news follows another successful year of trading for VetPlus owner, Tangerine Group, which recorded a turnover of £40.9m, up from £37.4m the previous year.
More than £1.6m of our Group’s profits are set to be reinvested back into the business to support further overseas expansion, as well as product development and significant upgrades in manufacturing facilities.